Stephen K. Doberstein
2011
In 2011, Stephen K. Doberstein earned a total compensation of $1M as Senior Vice President and Chief Scientific Officer at Nektar Therapeutics, a 71% decrease compared to previous year.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $221,550 |
| Option Awards | $346,506 |
| Salary | $420,167 |
| Other | $9,057 |
| Total | $1,017,280 |
Doberstein received $420.2K in salary, accounting for 41% of the total pay in 2011.
Doberstein also received $20K in bonus, $221.6K in non-equity incentive plan, $346.5K in option awards and $9.1K in other compensation.
Rankings
In 2011, Stephen K. Doberstein's compensation ranked 5,592nd out of 10,747 executives tracked by ExecPay. In other words, Doberstein earned more than 48.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,592 out of 10,747 | 48th |
Division Manufacturing | 2,034 out of 3,960 | 49th |
Major group Chemicals And Allied Products | 447 out of 1,033 | 57th |
Industry group Drugs | 283 out of 781 | 64th |
Industry Pharmaceutical Preparations | 222 out of 571 | 61st |
Source: SEC filing on April 30, 2014.
Doberstein's colleagues
We found four more compensation records of executives who worked with Stephen K. Doberstein at Nektar Therapeutics in 2011.